			Home About us Contact

Potential Utilization (potential + utilization)

Distribution by Scientific Domains

Life Sciences	50%

Selected Abstracts

Effect of Osteogenic Induction on the in Vitro Differentiation of Human Embryonic Stem Cells Cocultured With Periodontal Ligament Fibroblasts

ARTIFICIAL ORGANS, Issue 11 2007
Bülend Inanç
Abstract:, Osteogenesis is one of the principal components of periodontal tissue development as well as regeneration. As pluripotent cells with unlimited proliferative potential and differentiation ability to all germ layer representatives, embryonic stem cells also hold the promise to become a cell source in bone tissue engineering. Our aim was to investigate osteogenic differentiation potential of human embryonic stem cells (hESCs) under the inductive influence of human periodontal ligament fibroblast (hPDLF) monolayers. After being expanded and characterized morphologically and immunohistochemically, hESCs (HUES-9) were cocultured with hPDLFs for 28 days. Two groups were established: (i) osteogenic induction group with ascorbic acid, ,-glycerophosphate, and dexamethasone containing hESC differentiation medium; and (ii) spontaneous differentiation group cultured in hESC differentiation medium. Morphological shift in cells was analyzed under an inverted microscope, and immunohistochemistry was performed on fixed specimens at days 1 and 28 using antibodies against alkaline phosphatase, osteonectin, osteopontin, bone sialoprotein (BSP), and osteocalcin (OSC). Reverse transcription,polymerase chain reaction was utilized for the detection of octameric binding protein-4, BSP, and OSC expression at mRNA level. Mineralization was assessed using alizarin red, and the surface topology shift in colonies was demonstrated with scanning electron microscopy. Results indicate the feasibility of osteogenic differentiation of hESCs in coculture, and suggest a role of periodontal ligament fibroblasts in their differentiation patterns. Advances in the field could allow for potential utilization of hESCs in periodontal tissue engineering applications involving regeneration of bone in periodontal compartment lost as a result of destructive periodontal diseases. [source]

Protein feeds coproduction in biomass conversion to fuels and chemicals

BIOFUELS, BIOPRODUCTS AND BIOREFINING, Issue 2 2009
Bruce E. Dale
Abstract Agriculture has changed greatly in the past in response to changing human needs. Now agriculture is being called on to provide raw materials for very large-scale fuel and chemical production. Agriculture will change again in response to this demand and all producers and users of agricultural feedstocks will be affected by this change. For example, livestock feeding practices have already changed in response to the availability of distillers' grains from corn ethanol production. A fuels industry based on herbaceous biomass energy crops will be many-fold larger than the existing corn ethanol industry and will produce its own set of impacts on livestock feeding. We explore here one of these impacts: the availability of large new sources of feed protein from biomass energy crops. In addition to structural carbohydrates, such as cellulose and hemicellulose, herbaceous biomass energy crops can easily be produced with approximately 10% protein, called ,leaf protein'. This leaf protein, as exemplified by alfalfa leaf protein, is superior to soybean meal (SBM) protein in its biological value. Leaf protein recovery and processing fit well into many process flow diagrams for biomass fuels. When leaf protein is properly processed to concentrate it and remove antinutritional factors, as we have learned over the years to do with soybean meal protein, protein in leaf protein concentrate (LPC) will probably be at least as valuable in livestock diets as SBM protein. If LPC is used to meet 20% of total animal protein requirements (i.e., market penetration of 20%) then the potential utilization of leaf protein concentrate could reach as much as 24 million metric tons annually. This leaf protein will replace protein from SBM and other sources. This much leaf protein will reduce by approximately 16 million hectares the amount of land required to provide protein for livestock. Likewise the amount of land required to meet fuel needs will effectively be reduced by 8 million hectares because this land will effectively do ,double duty' by producing needed animal protein as well as feedstocks for fuel production. © 2009 Society of Chemical Industry and John Wiley & Sons, Ltd [source]

A mutant of the green alga Dunaliella salina constitutively accumulates zeaxanthin under all growth conditions

BIOTECHNOLOGY & BIOENGINEERING, Issue 1 2003
EonSeon Jin
Abstract A novel mutant (zea1) of the halotolerant unicellular green alga Dunaliella salina is impaired in the zeaxanthin epoxidation reaction, thereby lacking a number of the ,-branch xanthophylls. HPLC analysis revealed that the zea1 mutant lacks neoxanthin (N), violaxanthin (V) and antheraxanthin (A) but constitutively accumulates zeaxanthin (Z). Under low-light physiological growth conditions, the zea1 (6 mg Z per g dry weight or 8 × 10,16 mol Z/cell) had a substantially higher Z content than the wild type (0.2 mg Z per g dry weight or 0.5 × 10,16 mol Z/cell). Lack of N, V, and A did not affect photosynthesis or growth of the zea1 strain. Biochemical analyses suggested that Z constitutively and quantitatively substitutes for N, V, and A in the zea1 strain. This mutant is discussed in terms of its commercial value and potential utilization by the algal biotechnology industry for the production of zeaxanthin, a high-value bioproduct. © 2002 Wiley Periodicals, Inc. Biotechnol Bioeng 81: 115,124, 2003. [source]

Incorporation of 3T3-L1 Cells To Mimic Bioaccumulation in a Microscale Cell Culture Analog Device for Toxicity Studies

BIOTECHNOLOGY PROGRESS, Issue 2 2004
Kwanchanok Viravaidya
Deficiencies in the early ADMET (absorption, distribution, metabolism, elimination, and toxicity) information on drug candidates extract a significant economic penalty on pharmaceutical firms. We have developed a microscale cell culture analog (,CCA) device that can potentially provide better, faster, and more efficient prediction of human and animal responses to a wide range of chemicals. The system described in this paper is a simple four-chamber ,CCA ("lung","liver","fat","other tissue") designed on the basis of a physiologically based pharmacokinetics (PBPK) model of a rat. Cultures of L2, HepG2/C3A, and differentiated 3T3-L1 adipocytes were selected to mimic the key functions of the lung, liver, and fat compartments, respectively. Here, we have demonstrated the application of the ,CCA system to study bioaccumulation, distribution, and toxicity of selected compounds. Results from the bioaccumulation study reveal that hydrophobic compounds such as fluoranthene preferentially accumulated in the fat chamber. Only a small amount of fluoranthene was observed in the liver and lung chambers. In addition, the presence of the differentiated 3T3-L1 adipocytes in the ,CCA device significantly reduced naphthalene and naphthoquinone-induced glutathione (GSH) depletion. These findings suggest the potential utilization of the ,CCA system to assess ADMET characteristics of the compound of interest prior to animal or human trials. [source]